Mandeg, Jennie L.
HRN: 23-14-15 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/05/2023
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
06/05/2023
06/11/2023
IVTT
1.5g
Q6H
Breast Abscess
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes